Cellular Mechanisms Which Distinguish between Hormone‐ and Antihormone‐Activated Estrogen Receptor

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1749-6632.1995.tb31374.xPMID 7625716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions.

  1994cited by this paper
• Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription.

  1994cited by this paper
• Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior.

  1994cited by this paper
• Functional dissection of the yeast Cyc8–Tupl transcriptional co-repressor complex

  1994cited by this paper
• Transcriptional repression directed by the yeast α2 protein in vitro

  1994cited by this paper
• Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells.

  1994cited by this paper
• The global transcriptional regulators, SSN6 and TUP1, play distinct roles in the establishment of a repressive chromatin structure.

  1994cited by this paper
• Phylogeny of the steroid receptor superfamily.

  1994cited by this paper
• Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.

  1993cited by this paper
• Estrogen receptor mutations in breast cancer

  1993cited by this paper
• Steroid receptors and their associated proteins.

  1993cited by this paper
• Nuclear Hormone Receptors as Targets for New Drug Discovery

  1993cited by this paper
• Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.

  1993cited by this paper
• Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.

  1993cited by this paper
• Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.

  1993cited by this paper
• Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.

  1993cited by this paper
• Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

  1993cited by this paper
• Ssn6-Tup1 is a general repressor of transcription in yeast.

  1992cited by this paper
• Identification of a negative regulatory function for steroid receptors.

  1992cited by this paper
• Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation.

  1992cited by this paper
• A single amino acid that determines the sensitivity of progesterone receptors to RU486.

  1992cited by this paper
• Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast.

  1992cited by this paper
• The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.

  1992cited by this paper
• Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

  1992cited by this paper
• Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

  1992cited by this paper
• The CYC8 and TUP1 proteins involved in glucose repression in Saccharomyces cerevisiae are associated in a protein complex

  1991cited by this paper
• The steroid receptor superfamily: mechanisms of diversity

  1991cited by this paper
• In situ distinction between steroid receptor binding and transactivation at a target gene

  1991cited by this paper
• Tamoxifen in premenopausal patients with metastatic breast cancer: a review.

  1991cited by this paper
• Dopamine activation of an orphan of the steroid receptor superfamily

  1991cited by this paper
• Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper.

  1991cited by this paper
• Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors.

  1990cited by this paper
• Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen.

  1990cited by this paper
• Hormone-free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90.

  1990cited by this paper
• Cooperative binding of estrogen receptor to imperfect estrogen‐responsive DNA elements correlates with their synergistic hormone‐dependent enhancer activity.

  1989cited by this paper
• Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements.

  1989cited by this paper
• The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

  1988cited by this paper
• Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen.

  1988cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue.

  1987cited by this paper
• Molecular cloning of complementary DNA encoding the avian receptor for vitamin D.

  1987cited by this paper
• Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens.

  1987cited by this paper
• [Steroid hormone receptors in breast cancer].

  1984cited by this paper
• Steroid‐hormone receptors in breast cancer

  1984cited by this paper

• Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence

  2022cites this paper
• REPA: Applying Pathway Analysis to Genome-Wide Transcription Factor Binding Data.

  2018influential citation
• REPA: Applying Pathway Analysis to Genome-Wide Transcription Factor Binding Data

  2018influential citation
• Genetic landscape of clear cell endometrial cancer and the era of precision medicine

  2017cites this paper
• Mechanisms of action of 5α- tetrahydrocorticosterone, a novel anti-inflammatory glucocorticoid

  2015cites this paper
• Regulation expression pathway analysis (REPA): a novel method to facilitate biological interpretation of high throughput expression profiling data

  2015cites this paper
• Régulation de l’activité transcriptionnelle des récepteurs des estrogènes (ER) par le récepteur à chimiokine CXCR4 et les récepteurs à activité tyrosine kinase ErbB2 et ErbB3

  2014cites this paper
• Targeting the mineralocorticoid receptor in cardiovascular disease

  2013cites this paper
• Cracking the estrogen receptor's posttranslational code in breast tumors.

  2011cites this paper
• DOSE-DEPENDENT EFFECTS OF ESTRADIOL ON WORKING M E M O R Y A N D THE PHOSPHORYLATION OF cAMP RESPONSE ELEMENT-BINDING PROTEIN By K A T I A JOANNE SINOPOLI

  2009cites this paper
• Regulation of Estrogen Receptor alpha Ubiquitination and Proteasome-mediated Receptor Degradation

  2008cites this paper
• Endocrine signaling in ovarian surface epithelium and cancer.

  2007cites this paper
• Endocrine Modulating Agents

  2007cites this paper
• The Role of Endometrium in Endometriosis

  2006cites this paper
• Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site.

  2006cites this paper
• Steroid receptor specificity with reference to the estrogen receptor

  2005cites this paper
• Bringing molecular prognosis and prediction to the clinic.

  2005cites this paper
• Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line.

  2004cites this paper
• Estrogen and Progesterone Modulate Monocyte Cell Cycle Progression and Apoptosis

  2003cites this paper
• Effects of Xenoestrogens on T Lymphocytes: Modulation of bcl-2, p53, and Apoptosis

  2003cites this paper
• Full Activation of Estrogen Receptor α Activation Function-1 Induces Proliferation of Breast Cancer Cells*

  2003cites this paper
• Both N- and C-terminal transactivation functions of DNA-bound ERalpha are blocked by a novel synthetic estrogen ligand.

  2003cites this paper
• Etablierung von In-vitro-Methoden zur Bestimmung des endokrinen Potentials von Fremdstoffen

  2002cites this paper
• The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta.

  2002cites this paper
• The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ERα and ERβ

  2002cites this paper
• The Breast Cancer Phenotype and Endocrine Response: Implications for New Drug Development Initiatives

  2002cites this paper
• Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.

  2002cites this paper
• SERM Modulation of Gene Expression

  2002cites this paper
• Helix 12 in the human estrogen receptor (hER) is essential for the hER function by overcoming nucleosome repression in yeast

  2002cites this paper
• 17-β-ESTRADIOL SUPPRESSES IL-2 AND IL-2 RECEPTOR

  2001cites this paper
• Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.

  2001cites this paper
• The Tamoxifen-responsive Estrogen Receptor α Mutant D351Y Shows Reduced Tamoxifen-dependent Interaction with Corepressor Complexes*

  2001cites this paper
• 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A.

  2001cites this paper
• Differential Effects of Sex Steroids on T and B Cells: Modulation of Cell Cycle Phase Distribution, Apoptosis and bcl-2 Protein Levels

  2001cites this paper
• 17-beta-estradiol suppresses IL-2 and IL-2 receptor.

  2001cites this paper
• Estrogen, prolactin, and autoimmunity: actions and interactions.

  2001cites this paper
• Analyse der (anti-)östrogenen Wirkmechanismen von Raloxifen und Tamoxifen in Endometrium- und Mammakarzinomen

  2001cites this paper
• An Antiestrogen-responsive Estrogen Receptor-α Mutant (D351Y) Shows Weak AF-2 Activity in the Presence of Tamoxifen*

  2000cites this paper
• Modulation of the oestrogen receptor: a process with distinct susceptible steps.

  2000cites this paper
• Structure of the Estrogen Receptor Dimerization Domain Bound to an Antiestrogenic Phosphotyrosyl Peptide

  2000cites this paper
• Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

  2000cites this paper
• Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis.

  2000cites this paper
• Agonistic and synergistic activity of tamoxifen in a yeast model system.

  2000cites this paper
• Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen.

  2000cites this paper
• Ribozyme-mediated cleavage of the estrogen receptor messenger RNA and inhibition of receptor function in target cells.

  1999cites this paper
• The Estrogen Receptor β-Isoform (ERβ) of the Human Estrogen Receptor Modulates ERα Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens1.

  1999cites this paper
• Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF‐α‐induced apoptosis

  1999cites this paper
• Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

  1999cites this paper
• Molecular mechanisms of antiestrogen action

  1999cites this paper
• Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis.

  1999cites this paper
• Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium.

  1999cites this paper
• The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.

  1999cites this paper
• A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor γ-activating Properties*

  1998cites this paper
• Antiestrogen therapy: uncertainties and risk assessment.

  1998cites this paper
• Hormonal therapy of breast cancer.

  1998cites this paper
• Classification of Breast Cancer Cells on the Basis of a Functional Assay for Estrogen Receptor

  1998cites this paper
• Estrogenic effects of the synthetic aminoestrogen 17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol (pentolame).

  1998cites this paper
• Octylphenol (OP), an environmental estrogen, stimulates prolactin (PRL) gene expression.

  1997cites this paper
• [Estrogen receptors and the mammary gland].

  1997cites this paper
• BRCA1 expression is not directly responsive to estrogen

  1997cites this paper
• Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression

  1997cites this paper
• Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.

  1997cites this paper
• Molecular determinants of tissue selectivity in estrogen receptor modulators.

  1997cites this paper
• Chapter 19. Estrogen Receptor Modulators: Effects in Non-Traditional Target Tissues

  1996cites this paper
• Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat.

  1996cites this paper
• Effects of tamoxifen and ICI 164384 on protein synthesis and vectorial secretion in polarized rat uterine epithelial cells.

  1996cites this paper
• Selective estrogen receptor modulators (SERMs).

  1970cites this paper
• TITLE : Src-JNK Potentiation of Estrogen Receptor AF1 ; Mechanism , and Role in Estrogen Action in Breast Cancer

  year unknowninfluential citation